Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA5SP321 is a processed rRNA pseudogene in the human genome, derived from the 5S ribosomal RNA gene family. It is classified as a "pseudogene," specifically an "rRNA pseudogene," meaning it is a noncoding, nonfunctional DNA segment similar to the 5S ribosomal RNA gene. Unlike the functional 5S rRNA, which is a critical structural RNA component of the large ribosomal subunit and plays a role in maintaining ribosomal architecture and function[1][3], RNA5SP321 does not have a biological function and is not transcribed into a functional RNA molecule. It represents a genomic remnant without encoded protein or regulatory activity and is neither a drug target nor a diagnostic marker[5][4][2].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 321 (RNA5SP321).